Impact of the SARS-CoV-2 Pandemic on the Management and Prognosis of Infective Endocarditis
Authors:
- Lucie AilhaudLALucie Ailhaud
- Robinson Gravier-DumonceauRGRobinson Gravier-Dumonceau
- Florent ArregleFAFlorent Arregle
- Sandrine HubertSHSandrine Hubert
- Jean-Paul CasaltaJCJean-Paul Casalta
- Alberto RiberiARAlberto Riberi
- Laetitia TessonnierLTLaetitia Tessonnier
- Roch GiorgiRGRoch Giorgi
- Gilbert HabibGHGilbert Habib
- Frédérique GourietFGFrédérique Gouriet
Open Access
- 17 April 2024
- journal article
- research article
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (4) , 86
Abstract
Background: Infective endocarditis (IE) is a serious condition which is difficult to diagnose and to treat, both medically and surgically. Objectives: The objective of this study was to evaluate the impact of the SARS-CoV-2 pandemic on the management of patients with IE. Methods: We conducted a single-centre retrospective study including patients hospitalized for IE during the pandemic (Group 2) compared with the same period the year before (Group 1). We compared clinical, laboratory, imagery, therapeutic, and patient outcomes between the two groups. Results: A total of 283 patients were managed for possible or definite IE (164 in Group 1 and 119 in Group 2). There were more intravenous drug-related IE patients in Group 2 (p = 0.009). There was no significant difference in surgery including intra-cardiac device extraction (p = 0.412) or time to surgery (p = 0.894). The one-year mortality was similar in both groups (16% versus 17.7%, p = 0.704). The recurrence rate was not significantly different between the two groups (5.9% in Group 2 versus 9.1% in Group 1, p = 0.311). Conclusions: The SARS-CoV-2 pandemic did not appear to have had a negative impact on the management of patients with IE. Maintenance of the activities of the endocarditis team within the referral centre probably contributed to this result. Nevertheless, the high proportion of intravenous drug-addicted patients in the pandemic cohort suggests that the SARS-CoV-2 pandemic had a major psychosocial impact.Keywords
Funding Information
- Institut Hospitalo-Universitaire (IHU) (ANR-10-IAHU-03)
- National Research Agency under the “Investissements d’avenir” programme (ANR-10-IAHU-03)
- Région Provence Alpes Côte d’Azur (ANR-10-IAHU-03)
- European FEDER PRIMI funding (ANR-10-IAHU-03)
This publication has 27 references indexed in Scilit:
- Adult cardiac surgery during COVID-19 lockdown: Impact on activity and outcomes in a high-volume centreArchives of Cardiovascular Diseases, 2021
- Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditisClinical Microbiology and Infection, 2021
- Impact of COVID-19 pandemic on eye cancer care in United KingdomBritish Journal of Cancer, 2021
- A Plea Not to Forget Infective Endocarditis in COVID-19 EraJACC: Cardiovascular Imaging, 2020
- COVID-19 and addictionDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Psychosocial impact of COVID-19Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Addiction psychiatry and COVID-19: impact on patients and service provisionIrish Journal of Psychological Medicine, 2020
- Challenges in Infective EndocarditisArquivos Brasileiros de Cardiologia, 2017
- Repeat Infective Endocarditis: Differentiating Relapse from ReinfectionClinical Infectious Diseases, 2005
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987